Life Sciences News

06/05/2013
The Human Microbiome Gets A Big Pharma Investment
06/05/2013
Second Genome Closes Series A With $11.5M
04/30/2013
Biotech upstart joins Big Pharma cast on high-profile ‘breakthrough’ stage
04/25/2013
Vapotherm Closes $29 Mln Round
04/15/2013
Galleon Pharma Seeks $30M Series B
04/02/2013
Ra Pharma Forms First Corporate Alliance, Strikes $200M Deal With Merck
02/14/2013
Elcelyx Therapeutics Completes $20 Million Series C Financing
02/11/2013
Holaira Raises $10M for COPD Device
09/20/2012
Innovative Pulmonary Raises $10.6M for COPD Therapy Trials, Names New CEO
07/02/2012
Who’s Still Active Among the Early-Stage Biotech VC’s
05/30/2012
Kona Medical Secures $30M in Financing
05/28/2012
Medical Devices as Drug Replacements
05/16/2012
Ra Pharmaceuticals Unveils Hereditary Angioedema as Lead Program
05/15/2012
Promedior Moves Fibrosis Pipeline to Boston, Hires Shire Vet as CEO
03/28/2012
Relievant Medsystems Announces $30 Million Series D Financing

Links to other Web sites found here are provided to assist you in locating information. Morgenthaler is not responsible for the content of the Web sites found at these links, or beyond, and does not attest to the accuracy, completeness or timeliness of the information they contain. In addition, we have highlighted a select number portfolio companies on a number of our Web pages, but encourage you to review our entire portfolio listed in our Portfolio tabs.